Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > New Bunka Interview with Ted Ohashi

<< Previous

Bullboard Posts

Next >>

Comment by ranmanon Mar 22, 2022 4:36pm

87 Views

Post# 34535756

RE:RE:RE:RE:RE:New Bunka Interview with Ted Ohashi

Reduced my position. Took a few lumps. They aren't the same company I bought into.

When a company changes course you have to decide if you still want to travel that road with them. I don't like it. So, I'm out. Still own a bit, just in case they pull a rabbit out of their a**es

How aboth that LEXX today? On our way!! Hope you bought some.

$3.055

+0.175 (+6.08%)

CLOSED AT 4:00 PM ET ON Mar 22, 2022

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale